Compare the benefits and harms of drugs for obesity in our large network meta-analysis (262 trials including almost 100K patients). Some surprising results, such as as the effects on quality of life at 1 year. Have a look ! 👇
Despite substantial weight loss, most obesity drugs such as Wegovy and Mounjaro do not meaningfully improve quality of life and few show cardiovascular benefits at one year, finds a new study in The BMJ https://bit.ly/4gmXim6 Read the linked commentary https://bit.ly/4f67A7I